L-MentholCAS# 2216-51-5 |
- D-Isomenthol
Catalog No.:BCN8540
CAS No.:23283-97-8
- D-Menthol
Catalog No.:BCN4973
CAS No.:15356-60-2
- DL-Menthol
Catalog No.:BCN5950
CAS No.:15356-70-4
- Neoisomenthol
Catalog No.:BCC8169
CAS No.:20752-34-5
- Menthol
Catalog No.:BCN9045
CAS No.:89-78-1
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 2216-51-5 | SDF | Download SDF |
PubChem ID | 16666 | Appearance | Colorless crystals |
Formula | C10H20O | M.Wt | 156.27 |
Type of Compound | Monoterpenoids | Storage | Desiccate at -20°C |
Synonyms | L-Menthol; (-)-Menthol; Levomenthol; 89-78-1; Menthomenthol; L-(-)-Menthol; Hexahydrothymol | ||
Solubility | DMSO : 100 mg/mL (639.92 mM; Need ultrasonic) | ||
Chemical Name | (1R,2S,5R)-5-methyl-2-propan-2-ylcyclohexan-1-ol | ||
SMILES | CC1CCC(C(C1)O)C(C)C | ||
Standard InChIKey | NOOLISFMXDJSKH-KXUCPTDWSA-N | ||
Standard InChI | InChI=1S/C10H20O/c1-7(2)9-5-4-8(3)6-10(9)11/h7-11H,4-6H2,1-3H3/t8-,9+,10-/m1/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | Menthol is used in analgesic balms and also in foods and oral hygiene products for its fresh cooling sensation, menthol enhances cooling by interacting with the cold-sensitive thermoTRP channel TRPM8. L-Menthol has antiperistaltic and anti-inflammatory effects, clinical trials investigating the potential therapeutic efficacy of L-menthol for treatment of chronic inflammatory disorders such as bronchial asthma, colitis and allergic rhinitis seem worthwhile, it sprayed on the gastric mucosa significantly suppresses peristalsis with minimal adverse drug reactions during upper GI endoscopy. |
Targets | PGE | IL Receptor | LTB |
In vitro | The anti-inflammatory activity of L-menthol compared to mint oil in human monocytes in vitro: a novel perspective for its therapeutic use in inflammatory diseases.[Pubmed: 9889172]Eur J Med Res. 1998 Dec 16;3(12):539-45.The anti-inflammatory efficacy of monoterpenes is still unknown. In order to evaluate the potential role of L-Menthol and mint oil as an anti-inflammatory drug, preclinical in vitro-investigations were performed using LPS-stimulated monocytes from healthy volunteers.
|
In vivo | L-menthol improves adenoma detection rate during colonoscopy: a randomized trial.[Pubmed: 24573731]Endoscopy. 2014 Mar;46(3):196-202.Colonoscopy is one of the most reliable methods for the detection of colorectal neoplasms. However, colonic peristalsis during colonoscopy results in some neoplastic lesions being hidden from view and commonly requires an intravenous or intramuscular injection of antispasmodic agents, which may sometimes causes unexpected adverse reactions. The aim of this study was to evaluate the efficacy of L-Menthol spray as an antiperistaltic agent and its effect on adenoma detection.
Relieving thermal discomfort: Effects of sprayed L-menthol on perception, performance, and time trial cycling in the heat.[Pubmed: 25943672]Scand J Med Sci Sports. 2015 Jun;25 Suppl 1:211-8.L-Menthol stimulates cutaneous thermoreceptors and induces cool sensations improving thermal comfort, but has been linked to heat storage responses; this could increase risk of heat illness during self-paced exercise in the heat.Therefore, L-Menthol application could lead to a discrepancy between behavioral and autonomic thermoregulatory drivers. Antiperistaltic effect and safety of L-menthol sprayed on the gastric mucosa for upper GI endoscopy: a phase III, multicenter, randomized, double-blind, placebo-controlled study.[Pubmed: 21353674 ]Gastrointest Endosc. 2011 May;73(5):932-41.GI peristalsis during GI endoscopy commonly requires intravenous or intramuscular injection of antispasmodic agents, which sometimes cause unexpected adverse reactions.
Our ultimate goal was to evaluate whether the antiperistaltic effect of L-Menthol-based preparations facilitates endoscopic examinations in a clinical setting.
|
L-Menthol Dilution Calculator
L-Menthol Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 6.3992 mL | 31.9959 mL | 63.9918 mL | 127.9836 mL | 159.9795 mL |
5 mM | 1.2798 mL | 6.3992 mL | 12.7984 mL | 25.5967 mL | 31.9959 mL |
10 mM | 0.6399 mL | 3.1996 mL | 6.3992 mL | 12.7984 mL | 15.998 mL |
50 mM | 0.128 mL | 0.6399 mL | 1.2798 mL | 2.5597 mL | 3.1996 mL |
100 mM | 0.064 mL | 0.32 mL | 0.6399 mL | 1.2798 mL | 1.5998 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Boron tributoxide
Catalog No.:BCN8281
CAS No.:688-74-4
- 2,6-Dimethoxy-1-acetonylquinol
Catalog No.:BCN5052
CAS No.:2215-96-5
- 1-Benzyl-1H-indazol-3-ol
Catalog No.:BCC8458
CAS No.:2215-63-6
- Stigmastane-3,6-dione
Catalog No.:BCN5051
CAS No.:22149-69-5
- Hopane-3beta,22-diol
Catalog No.:BCN4852
CAS No.:22149-65-1
- Kaempferol 3-gentiobioside
Catalog No.:BCN3345
CAS No.:22149-35-5
- 11-Hydroxytabersonine
Catalog No.:BCN5050
CAS No.:22149-28-6
- 2 beta-Hydroxykolavelool
Catalog No.:BCN4671
CAS No.:221466-42-8
- 2-Oxokolavelool
Catalog No.:BCN4672
CAS No.:221466-41-7
- Fischeria A
Catalog No.:BCN3779
CAS No.:221456-63-9
- Cytochalasin D
Catalog No.:BCN5049
CAS No.:22144-77-0
- Pinosylvin
Catalog No.:BCN5048
CAS No.:22139-77-1
- OBAA
Catalog No.:BCC6716
CAS No.:221632-26-4
- Conocarpan
Catalog No.:BCN5053
CAS No.:221666-27-9
- Methylswertianin
Catalog No.:BCN8505
CAS No.:22172-17-4
- Zotarolimus(ABT-578)
Catalog No.:BCC5481
CAS No.:221877-54-9
- Macrocarpal N
Catalog No.:BCN5811
CAS No.:221899-21-4
- L-Canavanine sulfate
Catalog No.:BCC6746
CAS No.:2219-31-0
- Lyn peptide inhibitor
Catalog No.:BCC5895
CAS No.:222018-18-0
- Pyrantel Pamoate
Catalog No.:BCC4958
CAS No.:22204-24-6
- Naproxen
Catalog No.:BCC9091
CAS No.:22204-53-1
- Dihydroseselin
Catalog No.:BCN8258
CAS No.:2221-66-1
- Dehydroglaucine
Catalog No.:BCN2548
CAS No.:22212-26-6
- Cucurbitacin I
Catalog No.:BCC2439
CAS No.:2222-07-3
The anti-inflammatory activity of L-menthol compared to mint oil in human monocytes in vitro: a novel perspective for its therapeutic use in inflammatory diseases.[Pubmed:9889172]
Eur J Med Res. 1998 Dec 16;3(12):539-45.
The anti-inflammatory efficacy of monoterpenes is still unknown. In order to evaluate the potential role of L-Menthol and mint oil as an anti-inflammatory drug, preclinical in vitro-investigations were performed using LPS-stimulated monocytes from healthy volunteers. Arachidonic acid metabolism was assessed by measuring LTB subset4 and PGE subset2 as indicators for both the lipoxygenase and the cyclooxygenase pathways respectively. In addition, the anti-inflammatory effects of the two terpenes on IL-1beta production were analysed. - L-Menthol significantly suppressed the production of each of the three inflammation mediators by monocytes in vitro. LTB subset4 decreased by -64.4 +/- 10%, PGE subset2 by -56.6 +/- 8%, and IL-1beta by -64.2 +/- 7% respectively at L-Menthol concentrations within the presumed therapeutic range of about 10 superset-7 g/ml. In contrast, mint oil had a bimodal effect on PGE subset2 production: lower concentrations of 10 superset-10 to 10 superset-8 g/ml increased PGE subset2 up to 6-fold compared to baseline but concentrations of 10 superset-7 g/ml suppressed PGE subset2 production by approximately 50%. Mint oil had similar effects on LTB subset4 and IL-1beta as its main constituent, L-Menthol, although the degree of suppression was by comparison smaller at lower concentrations. Paraffin oil, which served as a solvent, did not affect arachidonic acid metabolism and IL-1beta production. - These results obtained with human monocytes suggest preferable anti-inflammatory effects of L-Menthol compared to mint oil at therapeutically relevant concentrations supplied in enteric coated capsules. Therefore, clinical trials investigating the potential therapeutic efficacy of L-Menthol for treatment of chronic inflammatory disorders such as bronchial asthma, colitis and allergic rhinitis seem worthwhile.
Antiperistaltic effect and safety of L-menthol sprayed on the gastric mucosa for upper GI endoscopy: a phase III, multicenter, randomized, double-blind, placebo-controlled study.[Pubmed:21353674]
Gastrointest Endosc. 2011 May;73(5):932-41.
BACKGROUND: GI peristalsis during GI endoscopy commonly requires intravenous or intramuscular injection of antispasmodic agents, which sometimes cause unexpected adverse reactions. OBJECTIVE: Our ultimate goal was to evaluate whether the antiperistaltic effect of L-Menthol-based preparations facilitates endoscopic examinations in a clinical setting. DESIGN: Multicenter, randomized, double-blind, placebo-controlled study. SETTING: Six Japanese referral centers. PATIENTS AND INTERVENTION: A total of 87 patients scheduled to undergo upper GI endoscopy were randomly assigned to receive 160 mg of L-Menthol (n=45) or placebo (n=42). Both treatments were sprayed endoscopically on the gastric mucosa. The degree of gastric peristalsis was assessed by an independent committee. MAIN OUTCOME MEASUREMENTS: The proportion of subjects with no peristalsis 90 to 135 seconds after administration and at the end of the endoscopic examination (complete suppression of gastric peristalsis). Other outcomes were the proportion of subjects with no or mild peristalsis (adequate suppression of gastric peristalsis) and the ease of intragastric observation as evaluated by the endoscopist who performed the procedure. RESULTS: Gastric peristalsis was completely suppressed in 35.6% (21.9, 51.2) of the L-Menthol group compared with only 7.1% (1.5, 19.5) of the placebo group (P<.001). In the L-Menthol group, 77.8% (62.9, 88.8) (35/45 subjects) of the subjects had no or mild peristalsis at the completion of endoscopy. Minor peristalsis interfered with intragastric examination in only 1 of these 35 patients (2.9%). The incidence of adverse events did not differ significantly between the groups (P=.512). LIMITATION: Small sample size. CONCLUSIONS: During upper GI endoscopy, L-Menthol sprayed on the gastric mucosa significantly suppresses peristalsis with minimal adverse drug reactions compared with placebo. ( CLINICAL TRIAL REGISTRATION NUMBER: NCT00742599.).
Relieving thermal discomfort: Effects of sprayed L-menthol on perception, performance, and time trial cycling in the heat.[Pubmed:25943672]
Scand J Med Sci Sports. 2015 Jun;25 Suppl 1:211-8.
L-Menthol stimulates cutaneous thermoreceptors and induces cool sensations improving thermal comfort, but has been linked to heat storage responses; this could increase risk of heat illness during self-paced exercise in the heat. Therefore, L-Menthol application could lead to a discrepancy between behavioral and autonomic thermoregulatory drivers. Eight male participants volunteered. They were familiarized and then completed two trials in hot conditions (33.5 degrees C, 33% relative humidity) where their t-shirt was sprayed with CONTROL-SPRAY or MENTHOL-SPRAY after 10 km (i.e., when they were hot and uncomfortable) of a 16.1-km cycling time trial (TT). Thermal perception [thermal sensation (TS) and comfort (TC)], thermal responses [rectal temperature (Trec ), skin temperature (Tskin )], perceived exertion (RPE), heart rate, pacing (power output), and TT completion time were measured. MENTHOL-SPRAY made participants feel cooler and more comfortable and resulted in lower RPE (i.e., less exertion) yet performance was unchanged [TT completion: CONTROL-SPRAY 32.4 (2.9) and MENTHOL-SPRAY 32.7 (3.0) min]. Trec rate of increase was 1.40 (0.60) and 1.45 (0.40) degrees C/h after CONTROL-SPRAY and MENTHOL-SPRAY application, which were not different. Spraying L-Menthol toward the end of self-paced exercise in the heat improved perception, but did not alter performance and did not increase heat illness risk.
L-menthol improves adenoma detection rate during colonoscopy: a randomized trial.[Pubmed:24573731]
Endoscopy. 2014 Mar;46(3):196-202.
BACKGROUND AND STUDY AIMS: Colonoscopy is one of the most reliable methods for the detection of colorectal neoplasms. However, colonic peristalsis during colonoscopy results in some neoplastic lesions being hidden from view and commonly requires an intravenous or intramuscular injection of antispasmodic agents, which may sometimes causes unexpected adverse reactions. The aim of this study was to evaluate the efficacy of L-Menthol spray as an antiperistaltic agent and its effect on adenoma detection. PATIENTS AND METHODS: This was a prospective, randomized, single-blind placebo-controlled trial. A total of 226 patients who were scheduled to undergo colonoscopy were randomly assigned to receive either 20 mL of 1.6 % L-Menthol (n = 118) or placebo (n = 108). Both treatments were sprayed locally onto the colonic mucosa via an endoscope. The adenoma detection rate (ADR) and the proportion of patients with no peristalsis were the primary and secondary outcomes, respectively. RESULTS: The ADR was significantly higher in the L-Menthol group than in the placebo group (60.2 % vs. 42.6 %; P = 0.0083). The proportion of patients with no peristalsis after treatment with L-Menthol was significantly higher than in the placebo group (71.2 % vs. 30.9 %; P < 0.0001). There were no adverse effects in either group. CONCLUSIONS: The results suggest that the suppression of colonic peristalsis by L-Menthol sprayed directly onto the colonic mucosa improves the ADR. CLINICAL TRIAL REGISTRATION: ID: UMIN 000007972.